PerkinElmer Buys GE Healthcare Radiochemical Products | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer announced today that it has purchased several radiochemical-related reagent assets from GE Healthcare.

Under the agreement, PerkinElmer will obtain GE Healthcare's 3H and 14C catalog radiochemicals, along with its Scintillation Proximity Assay (SPA) reagents and Cytostar-T plate product lines.

Catalog radiochemicals are used for a variety of research purposes including binding assays that may reveal possible drug candidates. The SPA and Cytostar-T plate products, meanwhile, allow high-throughput screening for such interactions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.